Zydus to initiate Phase III trials of biological therapy for Covid-19
PegiHep is an approved drug re-purposed for treating Covid-19. Credit: CDC on Unsplash.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more
